#rating
Latest news and interesting information about rating.
PDD Holdings SWOT: Temu growth vs regulatory risks
SWOT analysis of PDD Holdings: Temu growth, regulatory risks, financials, and price targets. Key insights for investors.
EuroDry Q1 net income $0.3M, orders two ships
EuroDry reports Q1 2026 net income of $0.3 million and orders two Kamsarmax vessels for 2028 delivery.
BMO Raises Israel Chemicals Target Price on Potash
BMO Capital raises Israel Chemicals price target to $6.50 on strong potash outlook and higher EBITDA guidance.
Cantor Fitzgerald raises PANW price target to $285
Cantor Fitzgerald raises Palo Alto Networks price target to $285, citing platformization, AI tailwinds, and strong partner results.
Stifel Maintains Manhattan Associates Price Target
Stifel maintains Buy rating and $200 target for Manhattan Associates. The company is investing in cloud migration and agentic AI capabilities.
Rosenblatt Raises 8x8 Target to $3.00
Rosenblatt raises 8x8 stock target to $3.00 after strong Q4 results. Revenue beat guidance.
Piper Sandler Reiterates Alphabet Overweight on AI
Piper Sandler reiterates Alphabet Overweight rating and $425 target after Google I/O AI product launches.
Rosenblatt Cuts Canaan Target Price to $1.30
Rosenblatt cuts Canaan stock price target to $1.30 from $2.25, maintains Buy rating. Canaan faces revenue miss in Q1 FY2026.
Bernstein raises Dell target to $280 on AI
Bernstein raises Dell price target to $280, citing agentic AI demand and SMCI share losses.
Alpha Tau Stock Gets Buy Rating, $15 Target
H.C. Wainwright reiterates Buy on Alpha Tau stock with $15 target. Company completes ReSTART trial enrollment.
H.C. Wainwright Reiterates Protara Buy Rating
H.C. Wainwright reiterates Buy rating on Protara Therapeutics (TARA) with $27 target. Encouraging results from lymphatic malformation and bladder cancer trials.
H.C. Wainwright reiterates MindWalk stock rating on platform validation
H.C. Wainwright reiterates Buy rating and $5 target on MindWalk stock, citing platform validation and strong pipeline. Read more.
Traws Pharma Gets $8 Price Target from H.C. Wainwright
H.C. Wainwright reaffirms Buy on Traws Pharma with $8 target. Financing secured for influenza drug trial. Read more on Bond.az.
Morgan Stanley raises ZTO target to $30.10
Morgan Stanley raises ZTO Express price target to $30.10 from $28.50, maintains Overweight rating, citing profit growth outlook.
Guggenheim reiterates Buy rating on Okta stock
Guggenheim reiterates Buy rating on Okta stock with $138 price target. Analysts expect Q1 earnings to beat consensus.
BTIG Lowers ServiceTitan Target, Keeps Buy
BTIG lowered ServiceTitan price target to $90 from $105, maintains Buy rating. Revenue growth 24.5%, gross margins 70%.
GE Aerospace Defense Outlook Boosts Stock Rating
RBC Capital praises GE Aerospace's defense outlook, reiterating Outperform rating. Read about strong earnings and new contracts.
Baku hosts sustainable cities forum
Baku hosts a high-level forum on sustainable cities, air quality, and green infrastructure. The event is part of WUF13 and initiated by IDEA.
Keefe Bruyette Reiterates Bitdeer Rating on AI Shift
Keefe, Bruyette & Woods reiterates Market Perform rating on Bitdeer stock with $11.50 target amid AI mix shift and Tydal project focus.
KeyBanc lowers Karman Holdings stock price target
KeyBanc lowered Karman Holdings price target to $100 from $122. Shares down 46% from highs. Analysts cut earnings forecasts.
KeyBanc Raises CryoPort Target to $17 on Growth
KeyBanc raises CryoPort price target to $17, citing revenue visibility and expanding margins. Overweight rating maintained.
KeyBanc Maintains Alphabet Rating on AI Growth
KeyBanc maintains Overweight rating on Alphabet stock with $425 target, citing AI growth and product transformation. PEG ratio of 0.63 indicates reasonable valuation.
BioStem Misses Q1 2026 Earnings, Stock Drops 14.88%
BioStem Technologies misses Q1 2026 earnings, stock falls 14.88%. Hospital revenue stable. Company guides FY2026 revenue $25-$29 million.
Jefferies upgrades Evonik, downgrades Lanxess on Iran spreads
Jefferies upgrades Evonik to 'buy' and downgrades Lanxess to 'underperform' citing Iran conflict-driven supply spikes. Detailed analysis on Bond.az.
ZTO Express Dips Despite Profit Growth, Market Share Gains
ZTO Express shares fall despite Q1 profit growth and market share gains. Read the full story on Bond.az.
Citizens Upgrades Toll Brothers Rating on Strong Earnings
Citizens upgrades Toll Brothers rating after strong Q2 earnings beat, highlighting price and volume performance.
Baozun Stock Up 4% on Earnings Beat
Baozun stock rises 4% after Q1 earnings beat and return to profit. E-commerce and brand management divisions drive strong results.
Stifel Raises Palo Alto Networks Target to $275
Stifel raises Palo Alto Networks price target to $275 amid strong demand and positive partner checks. Stock near 52-week high.
Raymond James Keeps Market Perform on CAVA
Raymond James maintains Market Perform rating on CAVA after impressive Q1 earnings with 9.7% comp sales growth and raised guidance.
Morgan Stanley hikes CAVA price target
Morgan Stanley raises CAVA price target to $86 on strong sales trends. Equalweight rating maintained despite valuation concerns.
...